Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Key Ratios

Price & Volume
Recent Price$1.35
52 Week High$2.42
52 Week Low$1.09
Average Volume (30 days)846.91K
Share Related Items
Market Cap$118.31M
Shares Outstanding88.29M
Dividend Information
Yield %--
Annual Dividend--
Payout Ratio-263.2%
Financial Strength
Quick Ratio (MRQ)8.4
Current Ratio (MRQ)8.5
LT Debt/Capital (MRQ)3%
Total Debt/Equity (MRQ)11%
Valuation Ratios
Price/Earnings (TTM)(4.50)
Price/Sales (TTM)--
Price/Book (MRQ)2.79
Price/Cash Flow (TTM)--
Per Share Data
Earnings (TTM)($0.30)
Sales (TTM)$0.00
Book Value (MRQ)$0.48
Cash Flow (TTM)($0.24)
Cash (MRQ)$0.55
Management Effectiveness
Return on Equity (TTM)-75.9%
Return on Assets (TTM)-51.9%
Return on Investment (TTM)-61.2%
Gross Margin (TTM)--
EBIT Margin (TTM)-11,269.0%
Profit Margin (TTM)--